On average when positive, Signatera tests have a 98%-99% rate of accurately predicting the presence of cancer depending on the cancer, and the false-positive rate is less than 2% to 1% depending on ...

Once you get the hang of the blood collection, you’re good to go. The herpes test kit comes with prepaid packaging ... Once selected, you could also opt for some add-ons such as a test for ...

Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its ...

Global clinical diagnostics market will reach $135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample ...

The global molecular diagnostic market size is projected to increase from USD 368.53 million in 2025 and is estimated to be worth around USD 542.97 m ...

QIAGEN N.V. today announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling. These new developments will be showcased at the American ...

RingConn sells the Gen 2 Air alongside the more expensive Gen 2 ($299), which offers a few upgrades, most notably sleep apnea detection capabilities. Despite their names, the standard Gen 2 weighs ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.